Photocure (PHO) - Total Liabilities
Based on the latest financial reports, Photocure (PHO) has total liabilities worth Nkr210.10 Million NOK (≈ $22.11 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore PHO cash flow metrics to assess how effectively this company generates cash.
Photocure - Total Liabilities Trend (2000–2024)
This chart illustrates how Photocure's total liabilities have evolved over time, based on quarterly financial data. Check financial resilience of Photocure to evaluate the company's liquid asset resilience ratio.
Photocure Competitors by Total Liabilities
The table below lists competitors of Photocure ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ador Welding Limited
NSE:ADORWELD
|
India | Rs1.87 Billion |
|
Dynacor Gold Mines Inc.
TO:DNG
|
Canada | CA$46.47 Million |
|
VAA Vista Alegre Atlantis SGPS SA
LS:VAF
|
Portugal | €169.16 Million |
|
Shangri-La Hotel Public Company Limited
BK:SHANG
|
Thailand | ฿528.09 Million |
|
Panion & BF Biotech Inc
TW:1760
|
Taiwan | NT$1.22 Billion |
|
Solid FAB
ST:SFAB
|
Sweden | Skr1.12 Billion |
|
PIE Industrial Bhd
KLSE:7095
|
Malaysia | RM165.48 Million |
|
Namsun Alumini
KO:008350
|
Korea | ₩144.33 Billion |
Liability Composition Analysis (2000–2024)
This chart breaks down Photocure's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see PHO company net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.25 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 2.81 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.43 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.30 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Photocure's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Photocure (2000–2024)
The table below shows the annual total liabilities of Photocure from 2000 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Nkr237.37 Million ≈ $24.98 Million |
+3.60% |
| 2023-12-31 | Nkr229.12 Million ≈ $24.11 Million |
-10.60% |
| 2022-12-31 | Nkr256.30 Million ≈ $26.97 Million |
-10.70% |
| 2021-12-31 | Nkr287.01 Million ≈ $30.20 Million |
+7.13% |
| 2020-12-31 | Nkr267.92 Million ≈ $28.19 Million |
+449.43% |
| 2019-12-31 | Nkr48.76 Million ≈ $5.13 Million |
-11.10% |
| 2018-12-31 | Nkr54.85 Million ≈ $5.77 Million |
+21.84% |
| 2017-12-31 | Nkr45.02 Million ≈ $4.74 Million |
+32.77% |
| 2016-12-31 | Nkr33.91 Million ≈ $3.57 Million |
-10.76% |
| 2015-12-31 | Nkr38.00 Million ≈ $4.00 Million |
+24.50% |
| 2014-12-31 | Nkr30.52 Million ≈ $3.21 Million |
-6.39% |
| 2013-12-31 | Nkr32.60 Million ≈ $3.43 Million |
-38.15% |
| 2012-12-31 | Nkr52.71 Million ≈ $5.55 Million |
-24.53% |
| 2011-12-31 | Nkr69.85 Million ≈ $7.35 Million |
+27.02% |
| 2010-12-31 | Nkr54.99 Million ≈ $5.79 Million |
+33.86% |
| 2009-12-31 | Nkr41.08 Million ≈ $4.32 Million |
+7.67% |
| 2008-12-31 | Nkr38.15 Million ≈ $4.01 Million |
-7.85% |
| 2007-12-31 | Nkr41.40 Million ≈ $4.36 Million |
-14.62% |
| 2006-12-31 | Nkr48.49 Million ≈ $5.10 Million |
-15.29% |
| 2005-12-31 | Nkr57.24 Million ≈ $6.02 Million |
-35.06% |
| 2004-12-31 | Nkr88.14 Million ≈ $9.28 Million |
-13.16% |
| 2003-12-31 | Nkr101.50 Million ≈ $10.68 Million |
-23.11% |
| 2002-12-31 | Nkr132.01 Million ≈ $13.89 Million |
+119.39% |
| 2001-12-31 | Nkr60.17 Million ≈ $6.33 Million |
+26.70% |
| 2000-12-31 | Nkr47.49 Million ≈ $5.00 Million |
-- |
About Photocure
Photocure ASA, together with its subsidiaries, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products. It operates through Commercial Franchise and Development Portfolio segments. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus-induced ce… Read more